UA104146C2 - ПОЛИМЕРНЫЕ КОНЪЮГАТЫ ФРАГМЕНТОВ ИНТЕРФЕРОНА-β, ЭРИТРОПОЭТИНА И ГОРМОНА РОСТА - Google Patents

ПОЛИМЕРНЫЕ КОНЪЮГАТЫ ФРАГМЕНТОВ ИНТЕРФЕРОНА-β, ЭРИТРОПОЭТИНА И ГОРМОНА РОСТА

Info

Publication number
UA104146C2
UA104146C2 UAA201102277A UAA201102277A UA104146C2 UA 104146 C2 UA104146 C2 UA 104146C2 UA A201102277 A UAA201102277 A UA A201102277A UA A201102277 A UAA201102277 A UA A201102277A UA 104146 C2 UA104146 C2 UA 104146C2
Authority
UA
Ukraine
Prior art keywords
moiety
interferon
erythropoietin
growth hormone
polymer conjugates
Prior art date
Application number
UAA201102277A
Other languages
English (en)
Ukrainian (uk)
Inventor
Ко-Чун Линь
Original Assignee
Фармаиссеншиа Корп.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармаиссеншиа Корп. filed Critical Фармаиссеншиа Корп.
Publication of UA104146C2 publication Critical patent/UA104146C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polyethers (AREA)

Abstract

Данное изобретение касается конъюгата полимерного фрагмента и фрагмента интерферона, фрагмента эритропоэтина или фрагмента гормона роста.
UAA201102277A 2008-07-31 2009-07-31 ПОЛИМЕРНЫЕ КОНЪЮГАТЫ ФРАГМЕНТОВ ИНТЕРФЕРОНА-β, ЭРИТРОПОЭТИНА И ГОРМОНА РОСТА UA104146C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8507208P 2008-07-31 2008-07-31
PCT/US2009/052347 WO2010014874A2 (en) 2008-07-31 2009-07-31 Peptide-polymer conjugates

Publications (1)

Publication Number Publication Date
UA104146C2 true UA104146C2 (ru) 2014-01-10

Family

ID=41609027

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201102277A UA104146C2 (ru) 2008-07-31 2009-07-31 ПОЛИМЕРНЫЕ КОНЪЮГАТЫ ФРАГМЕНТОВ ИНТЕРФЕРОНА-β, ЭРИТРОПОЭТИНА И ГОРМОНА РОСТА

Country Status (16)

Country Link
US (2) US8273343B2 (ru)
EP (1) EP2313457B1 (ru)
JP (1) JP5639585B2 (ru)
KR (1) KR101533757B1 (ru)
CN (1) CN102131844B (ru)
AR (1) AR072850A1 (ru)
AU (1) AU2009276458B2 (ru)
BR (1) BRPI0911722B1 (ru)
EA (1) EA020347B1 (ru)
HK (1) HK1158236A1 (ru)
MX (1) MX2011001167A (ru)
MY (1) MY156568A (ru)
NZ (1) NZ591167A (ru)
TW (1) TWI421093B (ru)
UA (1) UA104146C2 (ru)
WO (1) WO2010014874A2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11559567B2 (en) * 2014-11-06 2023-01-24 Pharmaessentia Corporation Dosage regimen for pegylated interferon

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3643575A (en) * 1967-10-31 1972-02-22 Nippon Kogaku Kk Exposure-measuring device in a single-lens reflex camera
US5919455A (en) * 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5951974A (en) * 1993-11-10 1999-09-14 Enzon, Inc. Interferon polymer conjugates
US5824784A (en) * 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
EP1191189A1 (de) * 2000-09-26 2002-03-27 Siemens Aktiengesellschaft Gasturbinenschaufel
US7257546B2 (en) * 2001-09-04 2007-08-14 Yahoo! Inc. System and method for correlating user data from a content provider and user data from an advertising provider that is stored on autonomous systems
BR0214451A (pt) * 2001-11-20 2006-05-30 Pharmacia Corp conjugados do hormÈnio do crescimento humano quimicamente modificado
AU2003210564B2 (en) * 2002-01-18 2008-10-23 Biogen Ma Inc. Polyalkylene glycol with moiety for conjugating biologically active compound
MXPA05002620A (es) 2002-09-09 2005-05-05 Nektar Therapeutics Al Corp Alcanales polimericos solubles en agua.
US20040142870A1 (en) * 2002-11-20 2004-07-22 Finn Rory F. N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
MXPA05006945A (es) * 2002-12-26 2005-12-14 Mountain View Pharmaceuticals Conjugados polimericos de citoquinas, quimiocinas, factores de crecimiento, hormonas polipeptidicas y sus antagonistas con actividad conservada de union al receptor.
NZ541374A (en) * 2003-05-23 2008-09-26 Nektar Therapeutics Al Corp PEG derivatives having an amidocarbonate linkage
MXPA06005732A (es) * 2003-11-24 2006-08-17 Neose Technologies Inc Eritropoyetina glucopegilada.
US20060024953A1 (en) * 2004-07-29 2006-02-02 Papa Rao Satyavolu S Dual damascene diffusion barrier/liner process with selective via-to-trench-bottom recess
JP2008511610A (ja) 2004-08-31 2008-04-17 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー グリセロール分岐のポリエチレングリコール−ヒト成長ホルモン結合体、それらの製造方法及び使用方法
US7524318B2 (en) * 2004-10-28 2009-04-28 Boston Scientific Scimed, Inc. Ablation probe with flared electrodes
WO2006094530A1 (en) * 2005-03-11 2006-09-14 Siegfried Ltd. Di-polymer protein conjugates and processes for their preparation
EP1869079A2 (en) * 2005-03-11 2007-12-26 Siegfried Ltd. Di-polymer protein conjugates and processes for their preparation
EP1834963A1 (en) * 2006-03-13 2007-09-19 Siegfried Ltd. Di-polymer protein conjugates and processes for their preparation
CL2008002399A1 (es) * 2007-08-16 2009-01-02 Pharmaessentia Corp Conjugado sustancialmente puro que posee una porcion polimerica, una porcion proteica (interferon alfa 2b) y un ligante alifatico de 1 a 10 atomos de carbono, util en el tratamiento de las hepatitis b o c.

Also Published As

Publication number Publication date
JP2011529910A (ja) 2011-12-15
BRPI0911722B1 (pt) 2022-09-13
KR20110059600A (ko) 2011-06-02
US20100029907A1 (en) 2010-02-04
EA020347B1 (ru) 2014-10-30
EA201170278A1 (ru) 2011-08-30
HK1158236A1 (zh) 2012-07-13
AU2009276458B2 (en) 2014-06-19
EP2313457B1 (en) 2020-01-15
US20110098451A1 (en) 2011-04-28
AU2009276458A1 (en) 2010-02-04
EP2313457A4 (en) 2014-10-01
BRPI0911722A2 (pt) 2016-09-13
KR101533757B1 (ko) 2015-07-03
TWI421093B (zh) 2014-01-01
JP5639585B2 (ja) 2014-12-10
WO2010014874A2 (en) 2010-02-04
NZ591167A (en) 2012-06-29
EP2313457A2 (en) 2011-04-27
CN102131844B (zh) 2016-03-02
CN102131844A (zh) 2011-07-20
AR072850A1 (es) 2010-09-22
MY156568A (en) 2016-03-15
MX2011001167A (es) 2011-04-12
TW201008583A (en) 2010-03-01
US8273343B2 (en) 2012-09-25
WO2010014874A3 (en) 2010-05-06

Similar Documents

Publication Publication Date Title
HK1207976A1 (en) Auristatin drug linker conjugates
IN2012DN00548A (ru)
IN2012DN00746A (ru)
EP2271359A4 (en) CAMPTOTHECINBINDING REST CONJUGATES
IL226267A0 (en) Compounds and polymers, preparations containing them and their uses
HK1211216A1 (en) Non-irritating ophthalmic povidone-iodine compositions
EP2332496A4 (en) Implanted soft palate supporter
MX2013002417A (es) Composiciones pesticidas.
IL218523A0 (en) Extracellular targeted drug conjugates
ZA201104495B (en) Conjugates of neurotensin or neurotensin analogs and uses thereof
HK1208876A1 (en) Factor viii polymer conjugates viii
IL211180B (en) Attached polyethylene glycol and docetaxel
EP2280619A4 (en) CLOTHING BELTS WITH POLYMERIC COMPOSITIONS
WO2009099768A3 (en) Biodegradable coatings for implantable medical devices
EA201200617A1 (ru) Полимеры на основе циклодекстрина для доставки лекарственных средств
EP2317911B8 (de) Transkutane organfunktionsmessung
WO2010042638A3 (en) Hpma - docetaxel or gemcitabine conjugates and uses therefore
EP2206502A4 (en) POLYMER CONJUGATE OF A STEROIDS
IL209337A0 (en) Conjugates of a cholinesterase moiety and a polymer, compositions, comprising the same and processes for the preparation of the same
EP2120966A4 (en) CONJUGATES OF RNA WITH SHORT INTERFERENCE POLYMERS
EP2296687A4 (en) PHARMACEUTICAL COMPOSITIONS OF SOMATOSTATIN DOPAMINE CONJUGATES
EP2201128A4 (en) POLYMERIZED CONJUGATES FOR BIOLOGICAL APPLICATIONS
HK1112673A1 (en) G-csf conjugates modified by water-soluble polymers
UA104146C2 (ru) ПОЛИМЕРНЫЕ КОНЪЮГАТЫ ФРАГМЕНТОВ ИНТЕРФЕРОНА-β, ЭРИТРОПОЭТИНА И ГОРМОНА РОСТА
EP2248832A4 (en) G-CSF CONJUGATE MODIFIED BY A WATER SOLUBLE POLYMER